Details for Patent: 11,858,898
✉ Email this page to a colleague
Which drugs does patent 11,858,898 protect, and when does it expire?
Patent 11,858,898 protects YUPELRI and is included in one NDA.
This patent has thirty-three patent family members in twenty-one countries.
Drugs Protected by US Patent 11,858,898
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan Ireland Ltd | YUPELRI | revefenacin | SOLUTION;INHALATION | 210598-001 | Nov 9, 2018 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | Y | FOR THE MAINTENANCE TREATMENT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) | ⤷ Sign Up | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,858,898
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2010273514 | ⤷ Sign Up | |||
| Brazil | 112012000890 | ⤷ Sign Up | |||
| Canada | 2765621 | ⤷ Sign Up | |||
| Canada | 2989129 | ⤷ Sign Up | |||
| China | 102470130 | ⤷ Sign Up | |||
| Cyprus | 1117075 | ⤷ Sign Up | |||
| Denmark | 2453894 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
